NORTH AMERICA CRISPR MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA CRISPR MARKET FORECAST 2019-2027

NORTH AMERICA CRISPR MARKET FORECAST 2019-2027

The North America CRISPR market is anticipated to exhibit a CAGR of 31.97% over the forecast period of 2019-2027. In terms of revenue generation, the market presently captures the largest share in the global CRISPR market. A major contribution for this region comes from the U.S, followed by Canada.

NORTH AMERICA CRISPR MARKET FORECAST 2019-2027

North America CRISPR Market by Product (Design Tools Product, Plasmids and Vectors Product, CAS9 Nuclease and GRNA Product, Delivery System Product) by End User (Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes) by Geography

Request free sample 

The North America CRISPR market is anticipated to exhibit a CAGR of 31.97% over the forecast period of 2019-2027. In terms of revenue generation, the market presently captures the largest share in the global CRISPR market.

A major contribution for this region comes from the U.S, followed by Canada. The U.S. holds 40% of the global pharmaceutical market, a fact, which substantially aids the CRISPR market’s progress. The country is driven by booming pharmaceutical and biotechnology industry. The US successfully edited the DNA of viable human embryos using powerful gene-editing tool CRISPR in 2017. The Canadian market, too, is driven by extensive government funding to promote the research.

Market giants like Novartis International Ag, Crispr Therapeutics Ag, Integrated DNA Technologies (IDT), Genscript, Editas Medicine, Cellectis Bioresearch Sas, Transposagen Biopharmaceuticals Inc, Precision Biosciences, Sigma-Aldrich (Merck), Origene Technologies Inc, Intellia Therapeutics Inc, etc. have their presence in this region.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

 

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • PLASMIDS HOLD THE LARGEST MARKET SHARE IN TERMS OF PRODUCTS
      • INDUSTRIAL BIOTECH IS THE FASTEST GROWING END USER
      • GENOME EDITING/ GENETIC ENGINEERING IS MAJORLY USED APPLICATION
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • INCREASING DEMAND FOR DRUG DISCOVERY
      • LATE PREGNANCIES LEADING TO BIRTH DISORDERS
      • RISK OF CONGENITAL ANAMOLITIES
      • AGING GERIATRIC POPULATION
      • CHANGING LIFESTYLES
      • PREVALENCE OF GENETIC DISORDERS
      • INCREASING GENETIC DISEASES
      • GROWING AWARENESS REGARDING GENE THERAPEUTICS
    • MARKET RESTRAINTS
      • POSSIBLE MISUSE OF CRISPR GENE EDITING TOOL
      • LACK OF AWARENESS
      • LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
      • STRINGENT REGULATIONS
    • MARKET OPPORTUNITIES
      • GENOME SURGERY TO REWRITE GENETIC DISORDERS
      • GROWING USAGES OF POTENTIAL APPLICATIONS OF CRISPR TECHNOLOGY
    • MARKET CHALLENGES
      • PROTECTION OF PATENT
      • ALTERNATE TECHNOLOGIES
      • ETHICAL ISSUES
  1. MARKET BY PRODUCT
    • DESIGN TOOLS
    • PLASMIDS
    • VECTORS
    • LIBRARY
    • CONTROL KITS
    • PROTEINS
    • GRNA
    • OTHER PRODUCTS
  2. MARKET BY END USER
    • BIOLOGICAL RESEARCH
    • AGRICULTURAL BIOTECH
    • INDUSTRIAL BIOTECH
    • THERAPEUTICS AND DRUG DISCOVERY
  3. MARKET BY APPLICATION
    • GENOME EDITING/ GENETIC ENGINEERING
    • GRNA DATABASE/GENE LIBRARY
    • CRISPR PLASMID
    • HUMAN STEM CELLS
    • CELL LINE ENGINEERING
  4. KEY ANALYTICS
    • PORTER’S 5 FORCE MODEL
      • THREATS OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • MARKET ETYMOLOGY
    • SUPPLY CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • REGULATORY BODIES
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • PATENT ANALYSIS
    • STRATEGIC RECOMMENDATION AND CONCLUSION
    • PIPELINE ANALYSIS
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPETITIVE ANALYSIS
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILE
      • ADDGENE
      • APPLIED STEMCELL, INC.
      • CARIBOU BIOSCIENCES INC.
      • CELLECTIS BIORESEARCH SAS
      • CRISPR THERAPEUTICS AG
      • DIACARTA, INC.
      • EDIGENE, INC.
      • EDITAS MEDICINE
      • GENECOPOEIA, INC.
      • GENEDATA AG
      • GENSCRIPT
      • HORIZON DISCOVERY PLC.
      • INTEGRATED DNA TECHNOLOGIES
      • INTELLIA THERAPEUTICS INC
      • LONZA GROUP AG
      • NEW ENGLAND BIOLABS INC
      • NOVARTIS INTERNATIONAL AG
      • ORIGENE TECHNOLOGIES INC
      • PRECISION BIOSCIENCES
      • SANGAMO THERAPEUTICS
      • SIGMA-ALDRICH (MERCK)
      • THERMO FISHER SCIENTIFIC
      • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
LIST OF TABLES

TABLE 1       NORTH AMERICA CRISPR MARKET 2019-2027 ($ MILLIONS)

TABLE 2       MAJOR CONCERNS RELATED WITH GENETIC ENGINEERING

TABLE 3       NORTH AMERICA CRISPR MARKET BY PRODUCT 2019-2027 ($ MILLIONS)

TABLE 4       TOOLS NAME AND THEIR PROVIDERS

TABLE 5       NORTH AMERICA DESIGN TOOLS MARKET 2019-2027 ($ MILLIONS)

TABLE 6       NORTH AMERICA PLASMIDS MARKET 2019-2027 ($ MILLIONS)

TABLE 7       NORTH AMERICA VECTORS MARKET 2019-2027 ($ MILLIONS)

TABLE 8       NORTH AMERICA LIBRARY MARKET 2019-2027 ($ MILLIONS)

TABLE 9       NORTH AMERICA CONTROL KITS MARKET 2019-2027 ($ MILLIONS)

TABLE 10     NORTH AMERICA PROTEINS MARKET 2019-2027 ($ MILLIONS)

TABLE 11     NORTH AMERICA GRNA MARKET 2019-2027 ($ MILLIONS)

TABLE 12     NORTH AMERICA OTHER PRODUCTS MARKET 2019-2027 ($ MILLIONS)

TABLE 13     NORTH AMERICA CRISPR MARKET BY END USER 2019-2027 ($ MILLIONS)

TABLE 14     NORTH AMERICA BIOLOGICAL RESEARCH MARKET 2019-2027 ($ MILLION)

TABLE 15     NORTH AMERICA AGRICULTURAL BIOTECH MARKET 2019-2027 ($ MILLION)

TABLE 16     NORTH AMERICA INDUSTRIAL BIOTECH MARKET 2019-2027 ($ MILLION)

TABLE 17     NORTH AMERICA THERAPEUTICS AND DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)

TABLE 18     NORTH AMERICA CRISPR MARKE BY APPLICATION 2019-2027 ($ MILLIONS)

TABLE 19     NORTH AMERICA GENOME EDITING/ GENETIC ENGINEERING MARKET 2019-2027 ($ MILLIONS)

TABLE 20     BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET

TABLE 21     TRAITS AND TECHNOLOGY HISTORY OF PLANT BIOTECH

TABLE 22     AGRICULTURE BIOTECH TRAITS INDUSTRY

TABLE 23     COMPANY RELATED TO AGRICULTURE BIOTECHNOLOGY INVOLVED IN GENOME EDITING TOOL CRISPR

TABLE 24     AGRICULTURAL BIOTECHNOLOGY COMPANY LICENSING CRISPR PRODUCTS

TABLE 25     KEY COMPETITORS IN THE AGRICULTURAL BIOLOGICALS INDUSTRY

TABLE 26     NORTH AMERICA GRNA DATABASE/GENE LIBRARY MARKET 2019-2027 ($ MILLIONS)

TABLE 27     NORTH AMERICA CRISPR PLASMID MARKET 2019-2027 ($ MILLIONS)

TABLE 28     NORTH AMERICA HUMAN STEM CELLS MARKET 2019-2027 ($ MILLIONS)

TABLE 29     NORTH AMERICA CELL LINE ENGINEERING MARKET 2019-2027 ($ MILLIONS)

TABLE 30     NORTH AMERICA CRISPER MARKET 2019-2027 ($ MILLION)

TABLE 31     NORTH AMERICA CRISPER MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 32     FUNDS ALLOCATED FOR RESEARCH ACTIVITIES IN BUDGET 2016

TABLE 33     GM CROPS GROWN IN CANADA

 

LIST OF FIGURES

FIGURE 1     FATALITIES INCREASING DUE TO LIFESTYLE ORIENTED DISEASES (IN THOUSAND)

FIGURE 2     NORTH AMERICA CRISPR MARKET BY DESIGN TOOLS 2019-2027 ($ MILLIONS)

FIGURE 3     NORTH AMERICA CRISPR MARKET BY PLASMIDS 2019-2027 ($ MILLIONS)

FIGURE 4     NORTH AMERICA CRISPR MARKET BY VECTORS 2019-2027 ($ MILLIONS)

FIGURE 5     NORTH AMERICA CRISPR MARKET BY LIBRARY 2019-2027 ($ MILLIONS)

FIGURE 6     NORTH AMERICA CRISPR MARKET BY CONTROL KITS 2019-2027 ($ MILLIONS)

FIGURE 7     NORTH AMERICA CRISPR MARKET BY PROTEINS 2019-2027 ($ MILLIONS)

FIGURE 8     NORTH AMERICA CRISPR MARKET BY GRNA 2019-2027 ($ MILLIONS)

FIGURE 9     NORTH AMERICA CRISPR MARKET BY OTHER PRODUCTS 2019-2027 ($ MILLIONS)

FIGURE 10   NORTH AMERICA CRISPR MARKET BY BIOLOGICAL RESEARCH 2019-2027 ($ MILLION)

FIGURE 11   NORTH AMERICA CRISPR MARKET BY AGRICULTURAL BIOTECH 2019-2027 ($ MILLION)

FIGURE 12   NORTH AMERICA CRISPR MARKET BY INDUSTRIAL BIOTECH2019-2027 ($ MILLION)

FIGURE 13   NORTH AMERICA CRISPR MARKET BY THERAPEUTICS AND DRUG DISCOVERY 2019-2027 ($ MILLION)

FIGURE 14   NORTH AMERICA CRISPR MARKET BY GENOME EDITING/ GENETIC ENGINEERING 2019-2027 ($ MILLIONS)

FIGURE 15   NORTH AMERICA CRISPR MARKET BY GRNA DATABASE/GENE LIBRARY 2019-2027 ($ MILLIONS)

FIGURE 16   NORTH AMERICA CRISPR MARKET BY CRISPR PLASMID 2019-2027 ($ MILLIONS)

FIGURE 17   NORTH AMERICA CRISPR MARKET BY HUMAN STEM CELLS 2019-2027 ($ MILLIONS)

FIGURE 18   NORTH AMERICA CRISPR MARKET BY CELL LINE ENGINEERING 2019-2027 ($ MILLIONS)

FIGURE 19   VALUE CHAIN ANALYSIS

FIGURE 20   NORTH AMERICA CRISPER MARKET 2019-2027 ($ MILLION)

FIGURE 21   ADOPTION OF GMO CROPS IN THE U.S. IN 2017 (%)

FIGURE 22   THE UNITED STATES CRISPR MARKET 2019-2027 ($ MILLION)

FIGURE 23   REASONS FOR ADOPTING GENETICALLY ENGINEERED CROP (BT COTTON)

FIGURE 24   GM CROPS GROWN IN CANADA

FIGURE 25   CANADA CRISPER MARKET 2019-2027 ($ MILLION)

FIGURE 26   CRISPR MARKET COMPANIES SHARE 2017 (%)

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET SEGMENTATION
    • MARKET BY PRODUCT
      • DESIGN TOOLS
      • PLASMIDS
      • VECTORS
      • LIBRARY
      • CONTROL KITS
      • PROTEINS
      • GRNA
      • OTHER PRODUCTS
    • MARKET BY END USER
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH
      • THERAPEUTICS AND DRUG DISCOVERY
    • MARKET BY APPLICATION
      • GENOME EDITING/ GENETIC ENGINEERING
      • GRNA DATABASE/GENE LIBRARY
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • CELL LINE ENGINEERING

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now